The present invention relates to certain substituted heterocycles of Formula (I) which are useful in the treatment of diseases related to lipid and carbohydrate metabolism, such as type 2 diabetes, adipocyte differentiation, uncontrolled proliferation, such as lymphoma, Hodgkin's Disease, leukemia, breast cancer, prostate cancer or cancers in general; and inflammation, such as osteoarthritis, rheumatoid arthritis, Crohn's Disease or Inflammatory Bowel Disease. ##STR1##

 
Web www.patentalert.com

< Kappa opioid receptor ligands

< Albumin fusion proteins

> Secreted and transmembrane polypeptides and nucleic acids encoding the same

> NR1H4 nuclear receptor binding compounds

~ 00226